pulmonary disease – Page 24 – Communicable Diseases Research

SARS-CoV-2 Myocarditis Due to Severe Obesity

Endocrinology/Diabetes/Metabolism

Published on 2021-05-172022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] acute respiratory syndrome affected Cardiomyopathies cause Chronic low-grade inflammation chronic obstructive Comorbidities Comorbidity coronavirus COVID covid-induced myocarditis creating Cytokines defined detrimental Diabetes Mellitus diagnosed Diseases Endocrine Excessive activation heart failure higher risk Hispanic hypertension individual Inflammation Inflammatory inflammatory storm Injury literature male morbidity morbidly obese Mortality Myocardial dysfunction myocardial injury myocarditis Myocardium obesity obesity-related illnesses organ damage Patient pulmonary disease renal SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pneumonia Severe infection vicious cycle virus
[DOI] 10.7759/cureus.15074 PMC 바로가기 [Article Type] Endocrinology/Diabetes/Metabolism

Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management

Article

Published on 2021-05-172022-10-28
Journal: Biomedicines [Category] COVID-19,

Impact of COVID-19 lockdown on the incidence and mortality of acute exacerbations of chronic obstructive pulmonary disease: national interrupted time series analyses for Scotland and Wales

Research Article

Published on 2021-05-172022-10-28
Journal: BMC Medicine [Category] COVID-19, SARS,

[키워드] 95% CI acute exacerbation acute exacerbation of chronic obstructive pulmonary disease Admission Analysis average changed changes in chronic obstructive COPD country COVID-19 COVID-19 lockdown COVID-19 pandemic death deaths estimate healthcare Hospital admission hypothesised Impact incidence incidence rate increase in linkage lockdown lockdown restriction Meta-analysis Mortality National outcomes primary care Public pulmonary disease recorded reduced reduction in reductions in respiratory infections Result resulting Self-management statistically significant substantial reduction supplementary material Transmission
[DOI] 10.1186/s12916-021-02000-w PMC 바로가기 [Article Type] Research Article

Mortality Rate and Characteristics of Deaths Following COVID-19 Vaccination

Medicine

Published on 2021-05-142022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

Assessment of the Association of COPD and Asthma with In-Hospital Mortality in Patients with COVID-19. A Systematic Review, Meta-Analysis, and Meta-Regression Analysis

Review

Published on 2021-05-132022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

RIG-I triggers a signaling-abortive anti-SARS-CoV-2 defense in human lung cells

Research

Published on 2021-05-112022-10-05
Journal: Nature Immunology [Category] SARS, 바이오마커,

[키워드] 3′ untranslated region abrogate Activation acute respiratory syndrome anti-SARS-CoV-2 Anti-SARS-CoV-2 Activity ATPase C-terminal domain caused chronic obstructive coronavirus Coronavirus disease 2019 cytokine Defense domains early phase efficient expressed Genetic global pandemic Helicase human lung cell human lung cells immune response Interaction interferon lack lung cell mechanism mitochondrial nucleic acid Pathways Patient protein expression pulmonary disease recognize Replication restored RIG-I RNA genome RNA-dependent RNA polymerase SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 replication stimulate the SARS-CoV-2 Treatment Trigger upregulation viral genome viral infection viral particle viral spike protein virus
[DOI] 10.1038/s41590-021-00942-0 [Article Type] Research

Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging

Research

Published on 2021-05-112022-10-05
Journal: Nature Aging [Category] 치료법,

Vaping Exacerbates Coronavirus-Related Pulmonary Infection in a Murine Model

Physiology

Published on 2021-05-102022-10-31
Journal: Frontiers in Physiology [Category] COVID-19,

[키워드] beta coronavirus Contact Control coronavirus coronavirus disease Coronavirus infection COVID-19 cytokine Cytokines death described develop disease disease severity dysregulation E-cigarette Evidence exacerbate Fever global pandemic Histopathology indicate Infectious disease Inflammation intranasal less lung means measure MHV-A59 mice Mild Model Mortality outbreak pathology pulmonary pulmonary disease pulmonary inflammation Respiratory disease respiratory droplet risk factor SARS-CoV-2 Severe respiratory distress severity smoking spirometry suffered syndrome the SARS-CoV-2 therapeutic intervention Toxicity transmitted while WHO World Health Organization
[DOI] 10.3389/fphys.2021.634839 PMC 바로가기 [Article Type] Physiology

The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients

COVID-19

Published on 2021-05-072022-10-31
Journal: Epidemiology and Health [Category] COVID-19,

[키워드] 95% CI 95% confidence interval adjusted Analysis Anatomy association center Chronic kidney disease chronic obstructive CKD clinical severity score Comorbidity conducted contribute Control COPD coronavirus disease COVID-19 CSS death Dementia Diabetes Mellitus discharged disease disease severity epidemiological heart failure Hospitalized hospitalized patient hypertension identify Illness severity increased risk Infectious disease information Korea Korean malignancy Medical resources Mild Mortality multinomial logistic regression Odds ratio outcome Oxygen treatment Patient patients hospitalized prevention provided pulmonary disease risk factor severity of COVID-19 significantly social network analysis statistically Symptoms with COVID-19
[DOI] 10.4178/epih.e2021035 PMC 바로가기 [Article Type] COVID-19

Effect of comorbid pulmonary disease on the severity of COVID ‐19: A systematic review and meta‐analysis

동반이환폐질환이 COVID-19의 중증도에 미치는 영향: 체계적 고찰 및 메타분석

Meta-Analysis

Published on 2021-05-062022-09-10
Journal: Respirology (Carlton, Vic.) [Category] MERS, SARS, 치료기술,

[키워드] 95% CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Analysis article association Asthma caused chronic obstructive chronic respiratory disease chronic respiratory diseases comorbid diseases COPD coronavirus coronavirus disease Coronavirus disease 2019 COVID COVID‐19 COVID‐19 CRD CRDs editorial Effect eligibility criteria eliminating Final final analysis FIVE increased risk Infection initial search International Lung diseases meta‐analysis obstructive pulmonary diseases Patient persistent pulmonary conditions pulmonary disease question respiratory SARS‐CoV‐2 severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severity Spread systematic review was performed Wuhan Wuhan, China
[DOI] 10.1111/resp.14049 PMC 바로가기 [Article Type] Meta-Analysis